Institute for Translational Psychiatry, University of Münster, Münster, Germany.
Department of Psychiatry, Psychosomatics, and Psychotherapy, Center for Mental Health, University Hospital of Würzburg, Würzburg, Germany.
Transl Psychiatry. 2024 Mar 7;14(1):137. doi: 10.1038/s41398-024-02799-x.
Although highly effective on average, exposure-based treatments do not work equally well for all patients with anxiety disorders. The identification of pre-treatment response-predicting patient characteristics may enable patient stratification. Preliminary research highlights the relevance of inhibitory fronto-limbic networks as such. We aimed to identify pre-treatment neural signatures differing between exposure treatment responders and non-responders in spider phobia and to validate results through rigorous replication. Data of a bi-centric intervention study comprised clinical phenotyping and pre-treatment resting-state functional connectivity (rsFC) data of n = 79 patients with spider phobia (discovery sample) and n = 69 patients (replication sample). RsFC data analyses were accomplished using the Matlab-based CONN-toolbox with harmonized analyses protocols at both sites. Treatment response was defined by a reduction of >30% symptom severity from pre- to post-treatment (Spider Phobia Questionnaire Score, primary outcome). Secondary outcome was defined by a reduction of >50% in a Behavioral Avoidance Test (BAT). Mean within-session fear reduction functioned as a process measure for exposure. Compared to non-responders and pre-treatment, results in the discovery sample seemed to indicate that responders exhibited stronger negative connectivity between frontal and limbic structures and were characterized by heightened connectivity between the amygdala and ventral visual pathway regions. Patients exhibiting high within-session fear reduction showed stronger excitatory connectivity within the prefrontal cortex than patients with low within-session fear reduction. Whereas these results could be replicated by another team using the same data (cross-team replication), cross-site replication of the discovery sample findings in the independent replication sample was unsuccessful. Results seem to support negative fronto-limbic connectivity as promising ingredient to enhance response rates in specific phobia but lack sufficient replication. Further research is needed to obtain a valid basis for clinical decision-making and the development of individually tailored treatment options. Notably, future studies should regularly include replication approaches in their protocols.
尽管基于暴露的治疗方法总体上非常有效,但对所有焦虑障碍患者的效果并不相同。识别治疗前可预测反应的患者特征可能使患者分层成为可能。初步研究强调了抑制性额 - 边缘网络的相关性。我们旨在确定蜘蛛恐惧症患者中暴露治疗反应者和非反应者之间存在差异的治疗前神经特征,并通过严格的复制来验证结果。这项双中心干预研究的数据包括临床表型和 n = 79 例蜘蛛恐惧症患者(发现样本)和 n = 69 例患者(复制样本)的治疗前静息状态功能连接(rsFC)数据。rsFC 数据分析是使用基于 Matlab 的 CONN-toolbox 完成的,两个站点都采用了协调的分析协议。治疗反应定义为从治疗前到治疗后的症状严重程度降低>30%(蜘蛛恐惧症问卷评分,主要结果)。次要结果定义为行为回避测试(BAT)降低>50%。单次治疗中的恐惧平均降低作为暴露的过程测量。与非反应者和治疗前相比,发现样本中的结果似乎表明,反应者在额叶和边缘结构之间表现出更强的负连接,并且在杏仁核和腹侧视觉通路区域之间表现出更高的连接。表现出高单次治疗中恐惧降低的患者比表现出低单次治疗中恐惧降低的患者在前额叶皮层内显示出更强的兴奋性连接。虽然另一组使用相同的数据(跨团队复制)可以复制这些结果,但在独立的复制样本中,发现样本的跨站点复制是不成功的。结果似乎支持负性额 - 边缘连接作为增强特定恐惧症反应率的有前途的成分,但缺乏足够的复制。需要进一步的研究来为临床决策和个体化治疗方案的制定提供有效的依据。值得注意的是,未来的研究应在其方案中定期纳入复制方法。